About LUCIOLE PHARMACEUTICALS, INC.
Luciole Pharmaceuticals is a start-up biotechnology company focused on discovering and developing small molecule activators of OGG1 to accelerate the repair of oxidative damage to mitochondrial DNA. The company applies cutting-edge science to enhance mitochondrial function and address age-related diseases.
Discovery and development of small molecule activators of OGG1Enhancement of mitochondrial DNA repair through base excision repair (BER) mechanismsResearch on mitochondrial dysfunction, oxidative stress, and inflammation in age-related diseasesApplication of virtual company model in drug discovery and development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LUCIOLE PHARMACEUTICALS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.